The Pros and Cons of TPN vs. Tube Feeding for Malnutrition

September 4, 2025

Understanding Nutritional Support Options for Malnutrition

Malnutrition remains a significant clinical challenge, especially in patients with impaired or non-functional gastrointestinal systems. The choice between Total Parenteral Nutrition (TPN) and enteral (tube) feeding is critical, shaped by numerous medical, anatomical, and situational factors. This article explores the key differences, benefits, risks, and decision-making considerations involved in selecting appropriate nutritional support for malnourished patients.

Overview of Nutritional Support Modalities

What are the main differences between Total Parenteral Nutrition (TPN) and enteral (tube) feeding?

Total Parenteral Nutrition (TPN) is delivered directly into a large vein via an intravenous catheter, bypassing the digestive system entirely. It provides a complete nutritional mixture, including carbohydrates, proteins, fats, vitamins, and minerals, typically administered over 10 to 24 hours. TPN is primarily used when the gastrointestinal (GI) tract cannot be used effectively, due to conditions like bowel obstruction, perforation, or severe malabsorption.

In contrast, enteral (tube) feeding involves delivering liquid nutrients directly into the stomach or small intestine through a feeding tube. This method leverages the natural digestive process, supporting gut function, immune health, and maintaining mucosal integrity. Enteral nutrition can be administered via various tubes such as nasogastric, gastrostomy, or jejunostomy tubes.

While TPN bypasses the GI tract, enteral feeding utilizes it, making the latter more physiological. TPN is typically reserved for long-term or complex cases with non-viable GI function, whereas tube feeding may be used temporarily or long-term if the gut can absorb nutrients but oral intake is inadequate or unsafe.

When should TPN be used instead of enteral nutrition?

TPN is the preferred method when the GI tract is non-functional or cannot be used effectively. This includes scenarios such as bowel obstruction, perforation, severe malabsorption, or extensive bowel resections that result in short bowel syndrome.

It’s indicated when the gut is accessible but cannot tolerate enteral feeding due to poor motility, inflammation, or after surgeries or radiotherapy affecting swallowing or gut integrity. For instance, patients with extensive small bowel disease or in cases of intestinal failure rely on TPN for nutritional sustenance.

Clinical assessment by a multidisciplinary team evaluates the patient’s overall condition, risks, and expected duration of nutritional support. Although enteral feeding remains the first choice whenever feasible, TPN is essential in situations where enteral nutrition is contraindicated or inadequate.

What are the advantages of tube feeding over TPN?

Tube feeding offers several benefits. It has a lower risk of bloodstream infections because it avoids placing a central venous catheter, which is common in TPN. Maintaining the gut’s function through enteral nutrition helps preserve the mucosal barrier, promotes immune health, and reduces bacterial translocation.

It is generally less costly, easier to administer, and less invasive, often being performed at bedside with minimal anesthesia. Additionally, tube feeding promotes gastrointestinal integrity, reducing the risk of intestinal atrophy, which can occur with the lack of enteral stimulation.

From a safety perspective, the lower complication risk makes tube feeding preferable for long-term use, especially for chronic patients. It also supports early recovery of gut function, potentially shortening hospital stays.

What are the risks and disadvantages associated with TPN?

TPN carries significant risks. Bloodstream infections are among the most serious complications, often related to catheter insertion or maintenance. Metabolic disturbances, such as hyperglycemia or electrolyte imbalances, require meticulous monitoring.

Long-term TPN therapy can result in liver dysfunction, including fatty liver changes or cholestasis, along with vascular complications like thrombosis or embolism. Nutritional imbalances, including deficiencies or excesses of trace elements, also pose concerns.

Additionally, TPN is costly, requiring specialized formulation and ongoing supervision by healthcare professionals. The invasive nature of central venous access increases the risk of mechanical complications, and improper management can lead to severe adverse outcomes.

What factors influence the choice between TPN and enteral nutrition?

The primary determinant is the functionality of the GI tract. If the patient’s gut can absorb and tolerate nutrients, enteral feeding is generally preferred due to lower risks and better support for gut health.

When the GI tract is compromised or inaccessible—due to obstruction, perforation, severe motility issues, or extensive bowel resection—TPN becomes necessary.

Other factors include the duration of support, patient’s overall condition, risk of aspiration, and potential for complications. Critical illness, postoperative state, or specific gastrointestinal diseases influence this decision.

What are the clinical considerations and decision factors when choosing a nutritional support method?

Clinicians assess multiple parameters: the patient’s nutritional status, GI tract competence, disease severity, risk of aspiration, and coexisting conditions.

Early initiation of nutritional support within 24-48 hours in critically ill or postoperative patients has been associated with better outcomes.

The feasibility of discreet, safe, and effective delivery influences choice—tubal feeding is less invasive and easier to implement long-term.

Ongoing evaluation to adjust nutrition methods in response to clinical changes is vital. Multidisciplinary teams — including physicians, dietitians, and nurses — guide tailored plans suited to patient needs.

Are there specific risks associated with TPN and how can they be mitigated?

TPN’s risks include catheter-related bloodstream infections, which can be minimized by strict aseptic technique during line insertion and maintenance.

Electrolyte imbalances, hyperglycemia, and liver issues require regular laboratory monitoring, prompt adjustments in nutrient formulations, and vigilant clinical observation.

Proper catheter care, timely removal of infected lines, and staff training significantly reduce infection rates.

In addition, individualized nutrient formulations and careful management of fluid and electrolyte balance help prevent metabolic disturbances.

Method Advantages Risks and Disadvantages Ideal Use Cases
Enteral (Tube) Feeding Supports gut function, lower infection risk, less costly Aspiration, tube dislodgement, GI intolerance, metabolic issues Patients with a functioning GI tract unable to eat enough
Total Parenteral Nutrition (TPN) Bypasses GI, customized nutrients, essential for gut rest Infection, metabolic disturbances, liver issues, cost GI non-function, bowel obstruction, severe malabsorption

Overall, the choice between TPN and enteral nutrition depends on a careful assessment of patient-specific factors, balancing benefits with potential risks to optimize clinical outcomes.

Physiological and Immunological Impact of Enteral Nutrition

What are the benefits of enteral nutrition in preserving gut and immune function?

Enteral nutrition plays a vital role in maintaining the structural and functional integrity of the gastrointestinal (GI) mucosa. When patients receive nutrients through the GI tract, it stimulates mucosal cells, preservation of mucosal thickness, and the overall integrity of the gut barrier. This is especially important in critically ill and malnourished patients, as a healthy gut barrier prevents bacterial translocation, which can lead to systemic infections.

Furthermore, enteral feeding supports the gut-associated lymphoid tissue (GALT), which is crucial for local and systemic immune responses. By nourishing the immune tissue within the gut, enteral nutrition enhances immune defenses and reduces susceptibility to infections.

Animal studies have provided strong evidence for these benefits. For instance, research indicates that enteral feeding reduces systemic inflammation and supports the immune system’s functionality. This evidence is supported by human studies demonstrating that patients fed via the enteral route experience fewer infections, reduced inflammatory markers, and improved outcomes in critical illnesses.

Overall, preserving gut mucosa and immune tissue through enteral nutrition helps prevent complications such as infections, sepsis, and systemic inflammatory response syndrome (SIRS), which are common in patients with compromised health or those experiencing severe illness.

Medical Applications and Indications for TPN and Enteral Feeding

In what clinical situations is TPN indicated?

Total Parenteral Nutrition (TPN) is mainly used in severe cases where the gastrointestinal (GI) tract cannot be used or is heavily impaired. These situations include bowel obstruction, perforation, short bowel syndrome, paralytic ileus, or extensive bowel resection. TPN becomes essential when conditions like Crohn’s disease, ischemic bowel, or post-surgical GI disruption prevent normal digestion and absorption.

Moreover, TPN is life-saving for patients with severe malabsorption, tumor-related intestinal obstructions, or when early oral or enteral feeding is contraindicated or impossible. This includes cases of severe trauma, burns, or during specific cancer treatments such as radiotherapy. The therapy provides complete nutritional support by delivering nutrients directly into the bloodstream, bypassing the digestive system entirely.

When is enteral nutrition favored in clinical practice?

Enteral nutrition (EN) is generally preferred when the digestive system functions properly and can absorb nutrients safely. It is favored in a variety of scenarios such as post-stroke dysphagia, head or neck cancers, neurological disorders affecting swallowing, and during early critical illness to prevent gut atrophy.

Additionally, EN is suitable for patients with mild to moderate malnutrition, especially after surgical interventions or in chronic conditions like dementia. Its less invasive nature, lower cost, and fewer complications make it the first choice in many settings.

EN also helps preserve gut integrity, supports immune function, and reduces systemic infections, making it a vital component of nutritional management in healthcare.

Are there specific disease states where TPN should be avoided?

While TPN can be crucial in certain conditions, it should generally be avoided or used cautiously in patients with high risks of infection or vascular access problems. For example, in patients where the risk of bloodstream infections is high or where reliable vascular access cannot be established, TPN poses significant hazards.

Furthermore, TPN is often avoided when nutritional support is not expected to improve patient outcomes, such as in terminal illnesses where artificial nutrition may not contribute to quality of life. Its high cost, complexity, and associated risks like metabolic disturbances and liver complications necessitate careful clinical judgment. In absence of clear indications, or when less invasive options suffice, clinicians favor enteral routes.

What are the considerations for pediatric and neonatal patients?

In pediatric and neonatal populations, TPN is frequently required when congenital intestinal anomalies, short bowel syndrome, or postoperative recovery from gastrointestinal surgery hinder adequate enteral feeding.

Pediatric TPN formulations are meticulously tailored to meet the specific growth, developmental, and metabolic needs of children. It requires continuous monitoring and support from specialized pediatric nutrition teams.

Risks include metabolic bone disease, liver issues, and micronutrient deficiencies, demanding diligent management. Longer-term TPN use in children often takes place at home, with caregivers trained in infusion techniques, emphasizing the importance of ongoing medical supervision and careful adjustment of nutrition plans.

How do the clinical indications differ in specific conditions such as cancer or critical illness?

In cancer patients, TPN may be employed when the tumor infiltration, surgical removal, or treatment-related mucositis impair oral or enteral feeding. It helps maintain weight, support the immune system, and improve treatment tolerance.

In critically ill patients, early enteral nutrition—started within 24 to 36 hours—is highly recommended to preserve gut integrity, reduce infection risk, and accelerate recovery. TPN is reserved for cases where enteral feeding is contraindicated, such as bowel paralysis or severe malabsorption.

The goal in both scenarios is to optimize nutritional status to support healing and immune function. The choice of route and timing depends on the patient's clinical stability, gastrointestinal function, and specific needs, emphasizing a tailored approach to nutritional support.

Comparison of Complication Profiles and Monitoring Needs

What are common complications associated with TPN and how can they be mitigated?

Total Parenteral Nutrition (TPN) is a life-saving intervention for patients with severely impaired or non-functional gastrointestinal tracts. However, it carries significant risks. Bloodstream infections are among the most common complications, often related to catheter use. Metabolic disturbances such as hyperglycemia, electrolyte imbalances, and liver dysfunction can also occur. Vascular issues like thrombosis further increase the risk.

To mitigate these complications, strict aseptic techniques during the insertion and maintenance of central venous catheters are critical. Regular monitoring of blood glucose levels, liver function tests, electrolytes, and triglycerides helps detect issues early. Tailoring the nutritional formulation to the patient's specific needs reduces metabolic risks. Ensuring meticulous line care and early detection of infection signs significantly lowers the chance of sepsis. Additionally, staff training and adherence to strict protocols are fundamental in preventing severe adverse outcomes.

What complications are linked to enteral feeding, and how are they managed?

Enteral feeding, while generally safer and more physiological than TPN, is not without risks. Aspiration pneumonia remains a primary concern, especially if the tube is misplaced or if the patient has impaired consciousness. Tube dislodgement and clogging can interrupt nutrition delivery and require prompt correction.

Gastrointestinal disturbances such as diarrhea, constipation, or nausea can also occur. Refeeding syndrome in malnourished patients is another serious complication. Management strategies include verifying proper tube placement through imaging or pH testing, regular site care, and monitoring patient tolerance.

Adjusting feeding formulas, administering prokinetics to improve gastric motility, and ensuring adequate water and electrolyte balance are crucial steps. Educating staff and caregivers on timely management of complications and intervention can significantly enhance safety and efficacy.

How does the risk of infection compare between TPN and tube feeding?

Research indicates that enteral nutrition via tube feeding has a noticeably lower risk of infection compared to TPN. This is primarily because TPN involves the placement of a central venous catheter, which is a potential site for bloodstream infections. In contrast, most enteral feeding methods do not require invasive bloodstream access.

The statistical data support this, showing a relative risk reduction for infections such as sepsis in patients receiving tube feeding. Moreover, standard care that supports oral intake or traditional feeding routes further reduces infection risks.

The lower incidence of infection makes enteral nutrition the preferred method whenever feasible, especially considering the severe consequences linked to catheter-related bloodstream infections.

What are the monitoring protocols necessary for safe TPN administration?

Ensuring the safety of TPN involves comprehensive and regular monitoring. Blood glucose levels should be checked frequently to avoid hyperglycemia. Electrolytes, liver enzymes, and renal function tests are conducted regularly to detect metabolic disturbances early.

Serum triglycerides are monitored to prevent hyperlipidemia, and catheter sites are examined routinely for signs of infection or thrombosis. Monitoring weight, input-output balance, and clinical status helps adjust the formulation and fluid management accordingly.

Long-term TPN therapy requires periodic review of micronutrient levels, including vitamins and minerals. Imaging studies or line inspections may be necessary to detect vascular complications.

Strict aseptic protocols during preparation and administration are essential, along with thorough staff training on complication recognition and intervention. This comprehensive approach minimizes risks and optimizes patient outcomes.

Aspect Enteral Nutrition Parenteral Nutrition Comparison Details
Risks Aspiration pneumonia, dislodgement, clogging, GI issues Infection, metabolic disturbances, vascular complications Enteral safer regarding infections; risks differ in nature
Monitoring Tube placement, tolerance, GI symptoms Blood glucose, electrolytes, liver function, catheter site Different parameters, both critical for safety
Management Proper tube care, adjusting formulas, early detection Line care, metabolic regulation, infection control Strategies tailored for each method
Infection Risk Lower Higher Significantly lower in enteral feeding
Cost Generally lower Higher Cost-effective advantage of EN
Overall Outcome Preserves gut function, reduces infection Essential when gut cannot be used Choice driven by patient condition

This comparison underscores the importance of selecting the appropriate nutritional support method based on patient condition, potential risks, and required monitoring protocols to ensure safety and efficacy.

Long-term Considerations and Quality of Life Aspects

What are the challenges of long-term TPN use?

Long-term use of total parenteral nutrition (TPN) presents several significant challenges that require careful management. One of the main concerns is the risk of catheter-related bloodstream infections, which can lead to serious complications such as sepsis. Regular monitoring of the infusion site, strict aseptic techniques, and proper catheter care are essential to reduce this risk.

Another challenge is the potential development of liver disease, particularly cholestasis and steatosis, associated with prolonged TPN use. These conditions can progress to liver failure if not detected early. Managing this involves adjusting nutritional components, monitoring liver function tests, and sometimes modifying the infusion protocol.

Metabolic bone disease, characterized by osteoporosis or osteomalacia, can occur due to imbalances in calcium, phosphate, and vitamin D levels. Regular assessment of mineral status and appropriate supplementation are necessary.

Micronutrient deficiencies, despite the complex formulations, can still occur and need to be periodically evaluated. Tailoring the nutritional mixture to the individual's needs helps prevent deficiencies.

Logistical challenges include ensuring a continuous supply of nutritional ingredients and infusion equipment, especially when managed at home. Resources such as specialized nursing care, caregiver training, and access to outpatient clinics are vital.

Managing vascular access sites involves not only preventing infections but also avoiding complications like thrombosis or catheter dislodgement. This requires skilled insertion procedures and ongoing follow-up.

The psychological impact of dependence on infusion therapy and long-term medical care must also be addressed. Patients may experience feelings of dependence or anxiety which need psychosocial support.

How does TPN impact patients’ quality of life?

The effects of TPN on quality of life are diverse and depend greatly on individual circumstances. For some patients, TPN is a lifesaver—restoring essential nutrients and improving overall health, which can lead to better functional status and increased independence.

However, managing TPN involves dealing with complex infusion setups, which often require continuous or frequent adjustments. The need for a central line or dual-lumen catheter can cause discomfort and restrict certain activities.

Fatigue and exhaustion related to continuous infusions and the burden of constant caregiving or medical supervision are common issues. Regular hospital visits for monitoring and potential complications may also impact daily routines.

On the other hand, many patients report feeling healthier, with improved energy levels and ability to engage in daily activities, which enhances their sense of well-being.

Psychologically, dependence on device and therapy can be challenging, but the knowledge that they are sustaining life provides relief and hope for many.

What are the prospects and considerations for home-based TPN?

Advancements in infusion technology, such as portable infusion pumps and remote monitoring systems, have made outpatient or home TPN increasingly feasible. These developments allow patients to maintain independence and experience a better quality of life outside hospital settings.

Implementing home TPN requires comprehensive patient and caregiver education regarding infusion procedures, catheter care, and emergency protocols. Ongoing training and support are essential to ensure safety.

Reliable access to supplies and immediate medical assistance in case of complications are critical components of a successful home program. Regular follow-up visits and laboratory testing are necessary to monitor for potential adverse effects like infections, metabolic derangements, or liver issues.

Support systems, including nursing visits and telemedicine consultations, help maintain safety and address concerns promptly. Patient adherence to strict infection prevention practices, such as hand hygiene and sterile techniques, is vital.

While home TPN offers many benefits, careful patient selection is necessary. Not all individuals are suitable candidates; those with severe cognitive impairments or lack of caregiver support may face increased risks.

In conclusion, while long-term TPN management involves challenges such as infection risk, metabolic complications, and logistical hurdles, ongoing advancements aim to mitigate these issues. When properly managed, home TPN can significantly improve patients’ lives by offering more autonomy and comfort, ultimately supporting better health outcomes.

Making Informed Nutritional Choices

Choosing between TPN and enteral feeding involves a nuanced understanding of clinical indications, patient condition, and the risk-benefit profile of each method. When the gastrointestinal tract is functional, enteral nutrition remains the preferred option due to its safety, cost-effectiveness, and physiological benefits. However, in cases of GI failure or obstruction, TPN provides essential nutritional support, albeit with higher risks and costs. Ongoing research, technological advances, and multidisciplinary care are vital in optimizing outcomes and enhancing patient quality of life. Ultimately, individualized assessment and careful monitoring are paramount to ensuring the most appropriate and effective nutritional support for malnourished or at-risk patients.

References

Dobutamine and Inotrope Therapy at Home
July 17, 2026
Learn how home dobutamine infusion works for advanced heart failure, who qualifies, how continuous inotrope therapy is managed at home, and how Pharmko supports cardiac patients and heart failure teams.
CIDP and Home Infusion: IVIG Treatment, Dosing Schedule, and Long-Term Management
July 16, 2026
Learn how IVIG therapy works for CIDP, what the dosing schedule looks like, how to transition to home infusion, and how Pharmko supports long-term CIDP management across 22+ states.
Compounded IV Medications
July 15, 2026
Most medications that patients receive at a hospital or pharmacy come in standardized, commercially manufactured forms, a 500mg antibiotic vial, a pre-filled syringe, a fixed-concentration IV bag. These products work well for many patients. But a significant portion of patients receiving IV therapy have clinical needs that commercial products cannot meet: a dose the manufacturer doesn't make, a formulation incompatible with the patient's allergy profile, or a combination of nutrients that must be tailored to individual lab values. For these patients, compounded IV medications are not optional, they are clinically necessary. Pharmko's sterile compounding services prepare customized IV medications for patients across 22+ states, with every formulation reviewed by a licensed pharmacist and prepared in a USP <797> compliant cleanroom. What Makes an IV Medication 'Compounded'? A compounded medication is one that is prepared specifically for an individual patient by a licensed pharmacist, rather than manufactured in bulk by a pharmaceutical company. Compounding involves combining, mixing, or altering ingredients, active pharmaceutical ingredients, diluents, preservatives, to create a final preparation that meets the patient's unique prescription requirements. For IV therapy specifically, compounding means preparing a sterile preparation, one that is completely free of viable microorganisms and safe to inject or infuse directly into the bloodstream. This requires specialized facilities, equipment, training, and quality systems that go far beyond what a standard retail pharmacy can provide. Pharmko is exclusively a sterile compounding pharmacy. We do not compound oral medications, topical creams, or non-sterile preparations. Every product we make is intended for intravenous, intraperitoneal, or subcutaneous administration. When Are Compounded IV Medications Necessary? The required dose doesn't exist commercially Pharmaceutical manufacturers produce medications in standardized strengths and volumes based on average patient needs. Pediatric patients, patients with renal or hepatic impairment requiring dose adjustments, or patients whose weight or clinical status falls outside standard ranges may need concentrations or volumes that no commercial product provides. Compounding fills this gap precisely. The patient has an allergy to a commercial formulation's inactive ingredients Commercial IV products often contain preservatives, stabilizers, or diluents, sulfites, benzyl alcohol, certain dyes, that some patients cannot tolerate. A compounding pharmacy can prepare an equivalent formulation without the offending ingredient, allowing the patient to receive the therapy safely. The medication requires individualized nutrient formulation Total parenteral nutrition (TPN) is the clearest example: every TPN formula must be individually compounded because no commercial product can provide the precise combination of amino acids, dextrose, lipids, electrolytes, vitamins, and trace minerals a specific patient needs. The formula changes as the patient's labs, weight, and clinical status change, making standardization impossible. The commercial product is unavailable or in shortage Drug shortages are a persistent reality in the US pharmaceutical supply chain. When a commercially manufactured IV medication becomes unavailable, compounding pharmacies can often prepare an equivalent formulation from available active pharmaceutical ingredients, bridging the gap and maintaining continuity of therapy for patients who cannot wait. The therapy requires a custom delivery format Some IV medications require specific pH, osmolarity, or concentration adjustments for compatibility with a patient's IV access device or concurrent medications. A compounding pharmacist reviews compatibility and prepares formulations that are safe and stable for the specific administration route and equipment the patient is using. How Compounded IV Medications Are Made Step 1: Prescription review Every compounded IV medication begins with a valid prescription from a licensed prescriber. Pharmko's pharmacists review the prescription for clinical appropriateness, dosing accuracy, ingredient compatibility, and stability before compounding begins. Step 2: Ingredient sourcing and verification Active pharmaceutical ingredients for compounding must come from FDA-registered suppliers and meet USP monograph specifications. Each lot is verified for identity, potency, and purity before use. Step 3: Sterile preparation in a controlled environment Preparation occurs in an ISO Class 5 laminar airflow workbench or biological safety cabinet, located within a buffer room that meets ISO Class 7 air quality standards. Pharmacy technicians follow validated, written procedures for each preparation type, using aseptic technique to prevent contamination at every step. Step 4: Pharmacist verification and release A licensed pharmacist performs a final check of every preparation, verifying appearance, volume, labeling, and documentation, before the product is released. High-risk or complex preparations may undergo sterility testing with defined beyond-use dates based on test results. Step 5: Cold-chain delivery Most compounded IV medications require refrigeration. Pharmko uses validated cold-chain packaging and delivery logistics to ensure products arrive within their stability windows and remain temperature-controlled until the patient uses them. Quality Standards That Matter Not all compounding pharmacies operate at the same standard. The relevant quality benchmarks for sterile compounding are: USP <797> compliance, the national standard for sterile compounding environments, personnel, and processes. Our guide on USP <797> and USP <800> explains what compliance means in practice ACHC accreditation, independent third-party verification that Pharmko meets clinical quality standards for home infusion and sterile compounding State pharmacy board licensure, Pharmko is licensed in every state where we serve patients Environmental and personnel monitoring, documented air and surface sampling, personnel gowning competency assessments, and media fill testing at defined intervals For a foundational overview of what sterile compounding is and how it differs from retail pharmacy, see our guide on what is sterile compounding for IV therapy . → Contact Pharmko about compounded IV medications: 1-877-540-2003
home infusion therapy Pennsylvania
July 14, 2026
Pharmko provides home infusion therapy across Pennsylvania, IV antibiotics, IVIG, TPN, biologics, and specialty medications. Licensed, ACHC accredited, and available 24/7 statewide.
Home Infusion Therapy in New Jersey
July 14, 2026
Pharmko provides home infusion therapy across New Jersey, IV antibiotics, IVIG, TPN, IDPN, biologics, and more. Licensed, ACHC accredited, and available 24/7 statewide.
Renal dietitian reviewing albumin labs for a peritoneal dialysis patient
July 10, 2026
When to consider IPN for peritoneal dialysis patients with low albumin: clinical criteria, the stepwise nutrition approach, and the referral process.
Nephrologist reviewing dialysis nutrition options for an ESRD patient
July 10, 2026
IPN vs. IDPN explained: how each parenteral nutrition therapy works, who qualifies, and how to choose the right option for ESRD dialysis patients.
How Home Infusion Reduces Hospital Readmissions
July 10, 2026
Home infusion therapy is associated with lower hospital readmission rates, fewer complications, and significant cost savings. Review the clinical evidence and learn how Pharmko supports discharge planning teams.
Primary Immune Deficiency and IVIG: A Guide for Newly Diagnosed Patients
July 8, 2026
Newly diagnosed with primary immune deficiency? Learn how IVIG therapy works, what to expect from your first infusions, how home IVIG is coordinated, and how Pharmko supports PID patients long-term.
Why They Matter and How Pharmko Customizes Your Formula
July 8, 2026
Trace minerals are essential components of every TPN formula. Learn what trace elements are included in parenteral nutrition, why each matters clinically, and how Pharmko pharmacists individualize your formula.
Show More